Product fact sheet
LACTAID Fast Act Lactase Enzyme Caplets
LACTAID Fast Act provides 9,000 FCC lactase units per caplet, taken with dairy; randomized lactase evidence supports lactose digestion, but symptom response is not guaranteed.
Fast Act provides 9,000 FCC lactase units per caplet. Randomized evidence supports oral lactase for lactose intolerance, while older product-comparison evidence shows that lower breath hydrogen does not always correspond to significant symptom relief.
People with lactose intolerance who want a targeted enzyme for lactose-containing meals, Consumers comparing enzyme products by stated FCC activity rather than vague proprietary blends
Treating unexplained chronic digestive symptoms without diagnosis, Exocrine pancreatic insufficiency, which generally requires prescribed pancreatic enzyme replacement therapy
Key tradeoff: Its single-enzyme, substrate-specific use is easier to map to clinical evidence than broad proprietary enzyme blends; symptom response still varies.
This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.
LACTAID Fast Act is a targeted digestive enzyme rather than a broad digestive-wellness blend. The current label states 9,000 FCC lactase units per caplet and ties use to lactose-containing food.
Mechanism and timing match the problem
Lactase breaks down lactose. The current product directions say to take a caplet with the first bite or sip of dairy and repeat after 30–45 minutes if dairy consumption continues.
Randomized controlled evidence supports oral lactase reducing symptoms and breath hydrogen in at least some adults with confirmed lactose intolerance.
A product-level caution from an older trial
An older randomized comparison of lactase preparations found that a Lactaid preparation reduced breath hydrogen but did not significantly reduce symptoms in that study.
That result does not erase the broader evidence for lactase. It shows that a physiological marker can improve without a matching symptom improvement in every study or person.
What this should not be used for
Lactase is specific to lactose. It is not a general treatment for chronic bloating, abdominal pain, celiac disease, inflammatory bowel disease or exocrine pancreatic insufficiency. NIDDK describes pancreatic enzyme replacement therapy as standard treatment for exocrine pancreatic insufficiency.
See Probiotics, Prebiotics & Digestive Enzymes for the targeted-enzyme decision framework.
Formula facts
Ingredients, actives and label details
- Activity
- 9,000 FCC lactase units per caplet Basis: Label Source: LACTAID Fast Act Lactase Enzyme Supplement Caplets
- Timing
- Take with the first bite or sip of dairy; repeat after 30–45 minutes if still consuming dairy per label Basis: Manufacturer Source: LACTAID Fast Act Lactase Enzyme Supplement Caplets
- Class efficacy
- Randomized crossover evidence supports oral lactase reducing breath hydrogen and symptoms in lactose intolerance Basis: Randomized controlled trial Source: Effect of lactase on symptoms and hydrogen breath levels in lactose intolerance
- Mixed product endpoint
- In a small 1994 comparison, Lactaid reduced breath hydrogen but did not significantly reduce symptoms Basis: Randomized controlled trial mixed A physiological response is not the same as symptom relief. Source: All lactase preparations are not the same: prospective randomized placebo-controlled trial
Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.
Safety first
What should make you slow down?
Use the product as directed, avoid treating concentrated wellness products as automatically harmless, and ask a qualified clinician when your situation or medication use makes the decision less routine.
Where to buy
Current tracked merchants
Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.
Source trail
Primary documents and supporting evidence
- LACTAID Fast Act Lactase Enzyme Supplement CapletsLACTAID · Manufacturer · retrieved 2026-08-11
- Treatment for Lactose IntoleranceNational Institute of Diabetes and Digestive and Kidney Diseases · Government clinical guidance · retrieved 2026-08-11
- Effect of lactase on symptoms and hydrogen breath levels in lactose intoleranceJGH Open / PubMed · Randomized controlled trial · retrieved 2026-08-11
- All lactase preparations are not the same: prospective randomized placebo-controlled trialPubMed · Randomized controlled trial · retrieved 2026-08-11